Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Survival Outcomes of Younger Patients With Mantle Cell Lymphoma Treated in the Rituximab Era.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Survival Outcomes of Younger Patients With Mantle Cell Lymphoma Treated in the Rituximab Era.
Survival Outcomes of Younger Patients With Mantle Cell Lymphoma Treated in the Rituximab Era. J Clin Oncol. 2019 02 20; 37(6):471-480.
View in:
PubMed
subject areas
Adult
Age Factors
Aged
Antineoplastic Agents, Immunological
Antineoplastic Combined Chemotherapy Protocols
Female
Hematopoietic Stem Cell Transplantation
Humans
Lymphoma, Mantle-Cell
Male
Middle Aged
North America
Retrospective Studies
Risk Assessment
Risk Factors
Rituximab
Time Factors
Transplantation, Autologous
Young Adult